Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the safety and tolerability of RN6G in patients with dry, age-related macular degeneration.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT07322302 · Trachoma, Eye Diseases, and more
NCT05414994 · Microbial Colonization, Eye Diseases, and more
NCT07228793 · Retinitis Pigmentosa, Eye Diseases
NCT06177639 · Eye Diseases
NCT05147701 · Eye Diseases, Retinitis Pigmentosa, and more
Dedicated Phase 1
Phoenix, Arizona
Retinal Consultants of AZ
Phoenix, Arizona
Insight Diagnostic Imaging Center
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions